Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Project Survival-Prospective Biomarker Discovery to Transform Diagnosis and Treatment for Patients With Pancreatic Diseases and Cancer

NCT02781012 is registered in ClinicalTrials.gov with Pancreatic Cancer Research Team as lead sponsor.

NCT NCT02781012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02781012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Project Survival-Prospective Biomarker Discovery to Transform Diagnosis and Treatment for Patients With Pancreatic Diseases and Cancer
Lead sponsor
Pancreatic Cancer Research Team
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2016
Completion date
February 28, 2022
Enrollment
436 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic cancer, pancreatic adenocarcinoma, pancreatic cancer, pancreatic neoplasms, pancreatitis